Long-Term Effects Secondary to Cancer Therapy in Children Terminated Phase 1 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0041542 (Long-Term Effects Secondary to Cancer Therapy in Children)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00238173Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain TumorsTreatment